Anti-Remicade antibodies also cross-react with infliximab biosimilar

Antibodies to the innovator infliximab drug Remicade found in rheumatoid arthritis and spondyloarthritis patients also cross-react with the infliximab biosimilar CT-P13, marketed as Remsima or...
Source: Rheumatology News - Category: Rheumatology Source Type: research